Microenvironmental Regulation of Proliferation in Multicellular Spheroids Is Mediated through Differential Expression of Cyclin-Dependent Kinase Inhibitors

Multicellular spheroids composed of transformed cells are known to mimic the growth characteristics of tumors and to develop gradients in proliferation with increasing size. This progressive accumulation of quiescent cells is presumably an active process that occurs in response to the microenvironmental stresses that develop within the three-dimensional structure, and, yet, little is known regarding either the signals that induce the cell cycle arrest or the molecular basis for the halt in proliferation. We have previously reported that regulation of cyclin-dependent kinase (CDK) inhibitors (CKIs) differs in monolayer versus spheroid cell culture. In this study, we have examined the expression of three CKIs in EMT6 mouse mammary carcinoma and MEL28 human melanoma spheroids, as a function both of spheroid size and of location within the spheroid. We report that expression of the CKIs p18INK4c, p21waf1/cip1, and p27Kip1 all increase as the spheroid grows and develops a quiescent cell fraction. However, by examining protein expression in discrete regions of the spheroid, we have found that only p18INK4c and p27Kip1 expression positively correlate with growth arrest, whereas p21waf1/cip1 is expressed predominantly in proliferating cells. Further analysis indicated that, in the quiescent cells, p18INK4c is found in increasing association with CDK6, whereas p27Kip1 associates predominantly with CDK2. In MEL28 cells, CDK2 activity is completely abrogated in the inner regions of the spheroid, whereas in EMT6 cells, CDK2 activity decreases in accordance with a decrease in expression. We also observed a decrease in all cell cycle regulatory proteins in the innermost spheroid fraction, including CDKs, CKIs, and cyclins. Induction of CKIs from separate families, as well as their association with distinct target CDKs, suggests that there may be multiple checkpoints activated to ensure cell cycle arrest in non-growth-conducive environments. Furthermore, because very similar observations were made in both a human melanoma cell line and a mouse mammary carcinoma cell line, our results indicate that these checkpoints, as well as the signal transduction pathways that activate them, are highly conserved.

[1]  R. Kerbel,et al.  Impact of the cyclin–dependent kinase inhibitor p27Kip1 on resistance of tumor cells to anticancer agents , 1996, Nature Medicine.

[2]  S. Asa,et al.  Overexpression of cyclin D1 and underexpression of p27 predict lymph node metastases in papillary thyroid carcinoma. , 2002, The Journal of clinical endocrinology and metabolism.

[3]  Herman Yeger,et al.  Decreased levels of the cell-cycle inhibitor p27Kip1 protein: Prognostic implications in primary breast cancer , 1997, Nature Medicine.

[4]  Partial purification of a protein growth inhibitor from multicellular spheroids. , 1988, Biochemical and biophysical research communications.

[5]  E. Choi,et al.  A non-enzymatic p21 protein inhibitor of stress-activated protein kinases , 1996, Nature.

[6]  M. Tomonaga,et al.  Alterations of the p27KIP1 gene in non-Hodgkin's lymphomas and adult T-cell leukemia/lymphoma. , 1995, Blood.

[7]  James M. Roberts,et al.  Expression of cell-cycle regulators p27Kip1 and cyclin E, alone and in combination, correlate with survival in young breast cancer patients , 1997, Nature Medicine.

[8]  T. Tsuruo,et al.  Up‐regulation of p27Kip1 Correlates Inversely with Anchorage‐independent Growth of Human Cancer Cell Lines , 1998, Japanese journal of cancer research : Gann.

[9]  G. delle Fave,et al.  p27: a potential main inhibitor of cell proliferation in digestive endocrine tumors but not a marker of benign behavior. , 2001, Human pathology.

[10]  J. Freyer,et al.  Regulation of growth saturation and development of necrosis in EMT6/Ro multicellular spheroids by the glucose and oxygen supply. , 1986, Cancer research.

[11]  James P. Freyer,et al.  Tumor growthin vivo and as multicellular spheroids compared by mathematical models , 1994, Bulletin of mathematical biology.

[12]  A. Schönthal,et al.  Activation of p53-p21 waf1 Pathway in Response to Disruption of Cell-Matrix Interactions* , 1997, The Journal of Biological Chemistry.

[13]  J. Pines Cyclin-dependent kinase inhibitors: the age of crystals. , 1997, Biochimica et biophysica acta.

[14]  A. Giaccia,et al.  The unique physiology of solid tumors: opportunities (and problems) for cancer therapy. , 1998, Cancer research.

[15]  F. Casagrande,et al.  Differential expression of G1 cyclins and cyclin-dependent kinase inhibitors in normal and transformed melanocytes. , 1998, Investigative ophthalmology & visual science.

[16]  J. Lapointe,et al.  A p18 mutant defective in CDK6 binding in human breast cancer cells. , 1996, Cancer research.

[17]  J. Bartek,et al.  High frequency of p16 (CDKN2/MTS-1/INK4A) inactivation in head and neck squamous cell carcinoma. , 1996, Cancer research.

[18]  W. Lee,et al.  Retinoblastoma protein and the cell cycle. , 1993, Current opinion in genetics & development.

[19]  R. Sutherland Cell and environment interactions in tumor microregions: the multicell spheroid model. , 1988, Science.

[20]  G. Hannon,et al.  Involvement of the cyclin-dependent kinase inhibitor p16 (INK4a) in replicative senescence of normal human fibroblasts. , 1996, Proceedings of the National Academy of Sciences of the United States of America.

[21]  J. Freyer Role of necrosis in regulating the growth saturation of multicellular spheroids. , 1988, Cancer research.

[22]  Sutherland,et al.  Tumor Hypoxia and Heterogeneity: Challenges and Opportunities for the Future. , 1996, Seminars in radiation oncology.

[23]  Philip D. Jeffrey,et al.  Crystal structure of the p27Kip1 cyclin-dependent-kinase inibitor bound to the cyclin A–Cdk2 complex , 1996, Nature.

[24]  P. Beer-Romero,et al.  Role of the ubiquitin-proteasome pathway in regulating abundance of the cyclin-dependent kinase inhibitor p27. , 1995, Science.

[25]  R. Strausberg,et al.  Transcriptional response to hypoxia in human tumors. , 2001, Journal of the National Cancer Institute.

[26]  M. Kawada,et al.  Induction of p27Kip1 degradation and anchorage independence by Ras through the MAP kinase signaling pathway , 1997, Oncogene.

[27]  Stephen J. Elledge,et al.  Mice Lacking p21 CIP1/WAF1 undergo normal development, but are defective in G1 checkpoint control , 1995, Cell.

[28]  D. Franklin,et al.  Induction of p18INK4c and its predominant association with CDK4 and CDK6 during myogenic differentiation. , 1996, Molecular biology of the cell.

[29]  J. Freyer,et al.  Differential regulation of cyclin-dependent kinase inhibitors in monolayer and spheroid cultures of tumorigenic and nontumorigenic fibroblasts. , 1998, Cancer research.

[30]  G. Strachan,et al.  An early S phase checkpoint is regulated by the E2F1 transcription factor. , 1999, Biochemical and biophysical research communications.

[31]  Yi-Song Wang,et al.  WAF1/CIP1 is induced in p53-mediated G1 arrest and apoptosis. , 1994, Cancer research.

[32]  G. Peters,et al.  Induced Expression of p16INK4a Inhibits Both CDK4- and CDK2-Associated Kinase Activity by Reassortment of Cyclin-CDK-Inhibitor Complexes , 1999, Molecular and Cellular Biology.

[33]  J. Massagué,et al.  Cyclic AMP-induced G1 phase arrest mediated by an inhibitor (p27 Kip1 ) of cyclin-dependent kinase 4 activation , 1994, Cell.

[34]  M. Loda,et al.  Low p27 expression predicts poor disease-free survival in patients with prostate cancer. , 1998, The Journal of urology.

[35]  R. Weinberg,et al.  The retinoblastoma protein and cell cycle control , 1995, Cell.

[36]  C. O'keefe,et al.  Growth suppression by p18, a p16INK4/MTS1- and p14INK4B/MTS2-related CDK6 inhibitor, correlates with wild-type pRb function. , 1994, Genes & development.

[37]  Y. Oda,et al.  Low expression of p27Kip1 is associated with tumor size and poor prognosis in patients with renal cell carcinoma , 2002 .

[38]  James M. Roberts,et al.  p27Kip1, a cyclin-Cdk inhibitor, links transforming growth factor-beta and contact inhibition to cell cycle arrest. , 1994, Genes & development.

[39]  Tony Hunter,et al.  p27, a novel inhibitor of G1 cyclin-Cdk protein kinase activity, is related to p21 , 1994, Cell.

[40]  F. Thaiss,et al.  High glucose stimulates expression of p27Kip1 in cultured mouse mesangial cells: relationship to hypertrophy. , 1997, The American journal of physiology.

[41]  T. Sano,et al.  Infrequent mutations of p27Kip1 gene and trisomy 12 in a subset of human pituitary adenomas. , 1997, The Journal of clinical endocrinology and metabolism.

[42]  Y. Oda,et al.  Low expression of p27(Kip1) is associated with tumor size and poor prognosis in patients with renal cell carcinoma. , 2002, Cancer.

[43]  J. Cheville,et al.  Expression of p27kip1 in prostatic adenocarcinoma. , 1998, Modern pathology : an official journal of the United States and Canadian Academy of Pathology, Inc.

[44]  A. Schönthal,et al.  p21WAF1 regulates anchorage-independent growth of HCT116 colon carcinoma cells via E-cadherin expression. , 2000, Cancer research.

[45]  H. Sack,et al.  Quiescent S-phase cells as indicators of extreme physiological conditions in human tumor xenografts. , 1999, International journal of radiation oncology, biology, physics.

[46]  J. Cheville,et al.  p27kip1: a multifunctional cyclin-dependent kinase inhibitor with prognostic significance in human cancers. , 1999, The American journal of pathology.

[47]  A. Takahashi,et al.  p53-dependent induction of WAF1 by a low-pH culture condition in human glioblastoma cells. , 1997, Cancer research.

[48]  R. Kerbel,et al.  Multicellular resistance: a new paradigm to explain aspects of acquired drug resistance of solid tumors. , 1994, Cold Spring Harbor symposia on quantitative biology.

[49]  M. Bulyk,et al.  Loss of the p16INK4a and p15INK4b genes, as well as neighboring 9p21 markers, in sporadic melanoma. , 1996, Cancer research.

[50]  M. Loda,et al.  Increased proteasome-dependent degradation of the cyclin-dependent kinase inhibitor p27 in aggressive colorectal carcinomas , 1997, Nature Medicine.

[51]  A. Cittadini,et al.  Reduced expression and altered subcellular localization of the cyclin‐dependent kinase inhibitor p27Kip1 in human colon cancer , 1999, Molecular carcinogenesis.

[52]  S. Elledge,et al.  The p21 Cdk-interacting protein Cip1 is a potent inhibitor of G1 cyclin-dependent kinases , 1993, Cell.

[53]  S. Cowper,et al.  Expression of p-27 (kip1) in nevi and melanomas. , 1999, The American Journal of dermatopathology.

[54]  M. Loda,et al.  Loss or altered subcellular localization of p27 in Barrett's associated adenocarcinoma. , 1998, Cancer research.

[55]  L. F. Fajardo,et al.  Characteristics of a serially transplanted mouse mammary tumor and its tissue-culture-adapted derivative. , 1972, Journal of the National Cancer Institute.

[56]  L. Hengst,et al.  Translational Control of p27Kip1 Accumulation During the Cell Cycle , 1996, Science.

[57]  P. Vaupel,et al.  The influence of tumor blood flow and microenvironmental factors on the efficacy of radiation, drugs and localized hyperthermia , 1997, Klinische Padiatrie.

[58]  J P Freyer,et al.  Rates of oxygen consumption for proliferating and quiescent cells isolated from multicellular tumor spheroids. , 1994, Advances in experimental medicine and biology.

[59]  A. Borkowski,et al.  Loss of cell cycle regulators p27(Kip1) and cyclin E in transitional cell carcinoma of the bladder correlates with tumor grade and patient survival. , 1999, The American journal of pathology.

[60]  Rolf Bjerkvig,et al.  Spheroid Culture in Cancer Research , 1991 .

[61]  Seongyong Kim,et al.  Alterations of CDKN2 (MTS1/p16INK4A) gene in paraffin-embedded tumor tissues of human stomach, lung, cervix and liver cancers , 1998, Experimental & Molecular Medicine.

[62]  A. Cittadini,et al.  Loss of P27Kip1 expression correlates with tumor grade and with reduced disease-free survival in primary superficial bladder cancers. , 1999, Cancer research.

[63]  H. Nojima,et al.  Induction of the Cyclin-dependent Kinase Inhibitor p21Sdi1/Cip1/Waf1 by Nitric Oxide-generating Vasodilator in Vascular Smooth Muscle Cells* , 1997, The Journal of Biological Chemistry.

[64]  H. Koeffler,et al.  p27/Kip1 mutation found in breast cancer. , 1996, Cancer research.

[65]  G. Hannon,et al.  p21-containing cyclin kinases exist in both active and inactive states. , 1994, Genes & development.

[66]  L. Jin,et al.  Aberrant p27kip1 expression in endocrine and other tumors. , 1997, The American journal of pathology.

[67]  J. Steinkamp,et al.  A new method for rapid and sensitive detection of bromodeoxyuridine in DNA-replicating cells. , 1987, Experimental cell research.

[68]  A. Reymond,et al.  p16 proteins from melanoma-prone families are deficient in binding to Cdk4. , 1995, Oncogene.

[69]  T. Hunter,et al.  Cyclins and cancer II: Cyclin D and CDK inhibitors come of age , 1994, Cell.

[70]  M. Roussel,et al.  Novel INK4 proteins, p19 and p18, are specific inhibitors of the cyclin D-dependent kinases CDK4 and CDK6 , 1995, Molecular and cellular biology.

[71]  L. Cooper,et al.  Expression of the p16 and p15 cyclin-dependent kinase inhibitors in lymphocyte activation and neuronal differentiation. , 1995, Cancer research.

[72]  D. Amadori,et al.  p27/kip1 expression in normal epithelium, benign and neoplastic breast lesions , 2002, The Journal of pathology.

[73]  J. P. Freyer,et al.  Influence of glucose and oxygen supply conditions on the oxygenation of multicellular spheroids. , 1986, British Journal of Cancer.

[74]  David O. Morgan,et al.  Principles of CDK regulation , 1995, Nature.

[75]  A. Borkowski,et al.  Loss of Cell Cycle Regulators p27Kip1 and Cyclin E in Transitional Cell Carcinoma of the Bladder Correlates with Tumor Grade and Patient Survival , 1999 .

[76]  T. Graeber,et al.  Hypoxia induces accumulation of p53 protein, but activation of a G1-phase checkpoint by low-oxygen conditions is independent of p53 status , 1994, Molecular and cellular biology.

[77]  James M. Roberts,et al.  Inhibitors of mammalian G1 cyclin-dependent kinases. , 1995, Genes & development.

[78]  G. Bradley,et al.  Reduced levels of the cell-cycle inhibitor p27Kip1 in epithelial dysplasia and carcinoma of the oral cavity. , 1998, The American journal of pathology.

[79]  J P Freyer,et al.  Regrowth kinetics of cells from different regions of multicellular spheroids of four cell lines , 1989, Journal of cellular physiology.

[80]  M. Loda,et al.  The cell cycle inhibitor p27 is an independent prognostic marker in small (T1a,b) invasive breast carcinomas. , 1997, Cancer research.

[81]  James M. Roberts,et al.  Requirement of p27Kip1 for Restriction Point Control of the Fibroblast Cell Cycle , 1996, Science.

[82]  J. Massagué,et al.  The subcellular locations of p15(Ink4b) and p27(Kip1) coordinate their inhibitory interactions with cdk4 and cdk2. , 1997, Genes & development.

[83]  L. Jin,et al.  DNA methylation regulates p27kip1 expression in rodent pituitary cell lines. , 1998, The American journal of pathology.

[84]  L. Klotz,et al.  Loss of cyclin-dependent kinase inhibitor p27Kip1 is a novel prognostic factor in localized human prostate adenocarcinoma. , 1998, Cancer research.

[85]  J P Freyer,et al.  Cellular energetics measured by phosphorous nuclear magnetic resonance spectroscopy are not correlated with chronic nutrient deficiency in multicellular tumor spheroids. , 1991, Cancer research.

[86]  J P Freyer,et al.  Decreased mitochondrial function in quiescent cells isolated from multicellular tumor spheroids , 1998, Journal of cellular physiology.

[87]  M. Clayton,et al.  Plateau-phase cultures: an experimental model for identifying drugs which are bioactivated within the microenvironment of solid tumours. , 1997, British Journal of Cancer.

[88]  J. LaBaer,et al.  New functional activities for the p21 family of CDK inhibitors. , 1997, Genes & development.

[89]  K. Kinzler,et al.  p21 is necessary for the p53-mediated G1 arrest in human cancer cells. , 1995, Cancer research.

[90]  L. Green,et al.  Role of Expression of Cell Cycle Inhibitor p27 and MIB‐1 in Predicting Lymph Node Metastasis in Male Breast Carcinoma , 2002, The breast journal.

[91]  J. Nesland,et al.  Protein expression of the cell-cycle inhibitor p27Kip1 in malignant melanoma: inverse correlation with disease-free survival. , 1998, The American journal of pathology.

[92]  D. Louis,et al.  Molecular Genetic Correlates of p16, cdk4, and pRb Immunohistochemistry in Glioblastomas , 1998, Journal of neuropathology and experimental neurology.